文献速递心力衰竭与心肌病

围产期、酒精性和癌症治疗相关心肌病的多基因易感性

Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies.
PubMed 文献 · JAMA Cardiol · 2025-01-01

IMPORTANCE: Rare monogenic variants linked to nonischemic dilated cardiomyopathy (DCM) are enriched among individuals with secondary cardiomyopathies, such as peripartum (PPCM), alcohol-induced (ACM), and cancer therapy-related (CCM) cardiomyopathies.…

要点

  • DCM多基因评分与PPCM、ACM、CCM风险显著相关(OR 1.56-1.82每SD)。
  • 多数继发性心肌病患者缺乏传统临床危险因素,提示遗传易感性贡献。
  • 单基因变异仅在少数患者中检出,多基因高风险更常见(66/113 vs 7/113)。

核心结论

  • PPCM、ACM和CCM患者中富集DCM单基因变异和高DCM多基因评分,提示继发性心肌病与DCM共享遗传结构。

主要发现

  • DCM多基因评分与PPCM相关(OR 1.82每SD,95%CI 1.43-2.30,P<.001)。
  • DCM多基因评分与ACM相关(OR 1.56每SD,95%CI 1.34-1.82,P<.001)。
  • DCM多基因评分与CCM相关(OR 1.64每SD,95%CI 1.24-2.15,P<.001)。
  • MGB中病历复核的113例心肌病患者中7例检出单基因变异,66例具有高多基因评分,后者约增加3倍心肌病风险。

临床怎么用

  • 对PPCM、ACM和CCM患者,可考虑评估DCM多基因风险以识别遗传易感个体。
  • 即使缺乏传统危险因素,也应警惕遗传因素在继发性心肌病中的作用。

局限性

  • 需更大样本量心肌病患者以确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Rare monogenic variants linked to nonischemic dilated cardiomyopathy (DCM) are enriched among individuals with secondary cardiomyopathies, such as peripartum (PPCM), alcohol-induced (ACM), and cancer therapy-related (CCM) cardiomyopathies. However, it remains unclear whether a polygenic predisposition to DCM also contributes to these conditions. OBJECTIVE: To assess the association of a DCM polygenic score with PPCM, ACM, and CCM, and to evaluate the contributions of monogenic and polygenic susceptibilities to these secondary cardiomyopathies. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective genetic association analysis of data from the Mass General Brigham (MGB) Biobank (n = 42 137, 2008-2025), with replication in the UK Biobank (n = 295 160, 2005-2010), FinnGen (n = 417 950, 2017-2025), and the Veterans Affairs Million Veteran Program (n = 516 066, 2011-2025). In MGB Biobank, medical records were reviewed to ascertain secondary cardiomyopathy cases and antecedent clinical risk factors. EXPOSURES: DCM polygenic risk score and DCM monogenic variants. MAIN OUTCOMES AND MEASURES: The primary outcomes were the association of the DCM polygenic risk score with PPCM, ACM, and CCM and the prevalence of monogenic variants and a high polygenic score among individuals with cardiomyopathy. RESULTS: The mean (SD) age in the MGB Biobank was 55.7 (17.0) years at enrollment, and 24 551 (58.3%) were female. Across the 4 study cohorts, 3414 individuals with secondary cardiomyopathy were identified, including 70 with PPCM, 2281 with ACM, and 1063 with CCM. The DCM polygenic score was associated with PPCM (odds ratio [OR], 1.82 per SD; 95% CI, 1.43-2.30), ACM (OR, 1.56; 95% CI,1.34-1.82), and CCM (OR, 1.64; 95% CI,1.24-2.15) (all with P < .001). Monogenic variants were enriched but present in 7 of 113 individuals with medical record-reviewed cardiomyopathy in MGB, while 66 had a high polygenic score, which conferred an approximately 3-fold increased odds of cardiomyopathy. Most individuals with cardiomyopathy lacked antecedent clinical risk factors. CONCLUSIONS AND RELEVANCE: In this cohort study, individuals with PPCM, ACM, and CCM were enriched for monogenic DCM variants and a high DCM polygenic score, suggesting a shared genetic susceptibility influenced by distinct environmental precipitants. These findings support a shared genetic architecture between secondary cardiomyopathies and DCM, although additional work with larger numbers of individuals with cardiomyopathy is needed to confirm these findings.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Maamari DJ, Biddinger KJ, Jurgens SJ, et al. Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies. JAMA Cardiol. 2025. PMID: 41032333. doi:10.1001/jamacardio.2025.3248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。